Clinical Value of Tocilizumab in Reducing Mortality in Refractory Septic Shock in Children with Hematologic and Non-Hematologic Diseases.

Cells · 2025 · PMC11941062 · PMID 40136690

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Among patients with septic shock, survivors usually show a decreasing trend of IL-6 levels, and non-survivors usually show increasing IL-6 levels [ 18 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.